USPTO 2015–2025 USPTO PatentsView US Corporation

Ekso Bionics Holdings, Inc.

USPTO PatentsView assignee record - 51 granted patents across 27 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI).

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Explore the portfolio See the ranking

Total patents granted

CPC technology areas

22.1

Avg claims per patent

-24%

5-year filing velocity

The verdict

Ekso holds 51 US patents across 27 technology areas, rank #6,524 of 50,000 tracked assignees.

#6,524
of 50,000 US assignees by volume: Top 18%
by Innovation Score (47.5/100): 22.1
avg claims per patent: -24%
filing velocity, last 5 yrs

Portfolio overview

Ekso Bionics Holdings, Inc. has been granted 51 US utility patents between 2015 and 2025, placing Ekso Bionics Holdings, Inc. at rank #6,524 across all assignees tracked by PlainPatent. This portfolio spans 27 distinct Cooperative Patent Classification (CPC) subclasses, averaging 22.1 claims per patent with primary concentration in A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFI). As a US Corporation, Ekso Bionics Holdings, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Ekso sits between Digital Ally, Inc. (51 patents, rank #6,520) and FKA Distributing Co., Llc (51 patents, rank #6,528) - the closest US assignees by grant volume. The composite Innovation Score of 47.5/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 22 grants, compared with 29 in the 2015–2019 window, a -24% shift in five-year velocity. A cooling filing rate may reflect portfolio consolidation, shifting priorities, or reduced R&D throughput. The US Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Ekso Bionics Holdings, Inc.'s 22.1 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while a multi-domain presence across 27 subclasses balances depth with breadth. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Ekso Bionics Holdings, Inc. against peers pursuing similar technology classes.

Digital Ally

51
Elite Material

51
Ezconn

51
Eden Collection B…

51
Elpis

51
Esaote S p A

51
Evertz Microsyste…

51
FKA Distributing

51
Ekso Bionics Hold… ◀

51

What this shows Ekso holds 51 patents at rank #6,524, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ekso

By rank, the assignees closest to #6,524 in granted patent volume.

Leaders in A61H (Physical Therapy Apparatus)

Other assignees with the most granted patents in Ekso's primary technology class.

Ekso's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

47 Top 18% higher than 82% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Ekso Bionics Holdings, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	3	5.9%
2016	3	5.9%
2017	5	9.8%
2018	4	7.8%
2019	14	27.5%
2020	8	15.7%
2021	2	3.9%
2023	6	11.8%
2024	2	3.9%
2025	4	7.8%

Which technologies does Ekso Bionics Holdings, Inc. patent most?

A61H - PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY 43

B25J - MANIPULATORS; CHAMBERS PROVIDED WITH MANIPULATION DEVICES 24

A61F - FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRS 17

A61B - DIAGNOSIS; SURGERY; IDENTIFICATION 6

F16M - FRAMES, CASINGS OR BEDS OF ENGINES, MACHINES OR APPARATUS, NOT SPECIFIC TO ENGINES, MACHINES OR APPARATUS PROVIDED FOR ELSEWHERE; STANDS; SUPPORTS 5

G05B - CONTROL OR REGULATING SYSTEMS IN GENERAL; FUNCTIONAL ELEMENTS OF SUCH SYSTEMS; MONITORING OR TESTING ARRANGEMENTS FOR SUCH SYSTEMS OR ELEMENTS 4

G16H - HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA 4

Y10S - TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS 3

B25H - WORKSHOP EQUIPMENT, e.g. FOR MARKING-OUT WORK; STORAGE MEANS FOR WORKSHOPS 3

F16H - GEARING 3

Y02E - REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION 2

A45F - TRAVELLING OR CAMP EQUIPMENT: SACKS OR PACKS CARRIED ON THE BODY 2

H01M - PROCESSES OR MEANS, e.g. BATTERIES, FOR THE DIRECT CONVERSION OF CHEMICAL ENERGY INTO ELECTRICAL ENERGY 2

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2

B65G - TRANSPORT OR STORAGE DEVICES, e.g. CONVEYORS FOR LOADING OR TIPPING, SHOP CONVEYOR SYSTEMS OR PNEUMATIC TUBE CONVEYORS 1

Top 15 of 27 technology areas

Patent Moat Analysis

Portfolio Volume Light

Tech Breadth Multi-domain

Claim Depth Complex

Velocity Declining

Where it ranks

Overall rank by patents

#6,524

Across all tracked assignees

Innovation Score

47.5 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Ekso Bionics Holdings, Inc. hold?

Ekso Bionics Holdings, Inc. holds 51 US granted patents filed between 2015 and 2025, spanning 27 technology areas.

What is Ekso Bionics Holdings, Inc.'s Innovation Score?

Ekso Bionics Holdings, Inc. has an Innovation Score of 47.5 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ekso Bionics Holdings, Inc. focus on?

Ekso Bionics Holdings, Inc.'s top technology area is A61H (PHYSICAL THERAPY APPARATUS, e.g. DEVICES FOR LOCATING OR STIMULATING REFLEX POINTS IN THE BODY; ARTIFICIAL RESPIRATION; MASSAGE; BATHING DEVICES FOR SPECIAL THERAPEUTIC OR HYGIENIC PURPOSES OR SPECIFIC PARTS OF THE BODY) with 43 patents. The company has filed patents in 27 CPC subclasses total.

Is Ekso Bionics Holdings, Inc.'s patent filing rate increasing or decreasing?

Ekso Bionics Holdings, Inc.'s recent filing velocity is -24% compared to the prior five-year period. Filing activity has slowed relative to earlier years.

What does claim depth mean for Ekso Bionics Holdings, Inc.'s patents?

Ekso Bionics Holdings, Inc.'s patents average 22.1 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.

How is the Ekso Bionics Holdings, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Ekso's 51 grants land it in the top 18% by Innovation Score, but volume alone doesn't tell you where the strength sits.

Read that count against the largest US assignees before treating it as dominance - Ekso ranks #6,524 of 50,000. Top 50 holders
Most of this portfolio concentrates in A61H - see who else leads that technology area. A61H leaders
Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled byPlainPatent Editorial, US Patent Intelligence Editorial Team · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.